tradingkey.logo
tradingkey.logo
Pesquisar

Clearpoint Neuro Inc

CLPT
Adicionar à lista de desejos
11.640USD
-1.130-8.85%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
349.08MValor de mercado
PerdaP/L TTM

Mais detalhes de Clearpoint Neuro Inc Empresa

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Informações de Clearpoint Neuro Inc

Código da empresaCLPT
Nome da EmpresaClearpoint Neuro Inc
Data de listagemJul 03, 2019
CEOBurnett (Joseph Michael)
Número de funcionários115
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 03
Endereço120 S. Sierra Avenue
CidadeSOLANA BEACH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92075
Telefone19499006833
Sitehttps://www.clearpointneuro.com/
Código da empresaCLPT
Data de listagemJul 03, 2019
CEOBurnett (Joseph Michael)

Executivos da empresa Clearpoint Neuro Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
+10.88%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
80.20K
+0.55%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
--
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
--
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
+10.88%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
80.20K
+0.55%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
--
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
--
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Products: Functional neurosurgery
14.83M
40.12%
Services: Biologics and drug delivery
11.70M
31.65%
Products: Biologics and drug delivery
7.34M
19.85%
Product Systems and software products
1.69M
4.57%
Services: Capital equipment and other
1.41M
3.81%
Por RegiãoUSD
Nome
Receita
Proporção
United States
36.97M
100.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Products: Functional neurosurgery
14.83M
40.12%
Services: Biologics and drug delivery
11.70M
31.65%
Products: Biologics and drug delivery
7.34M
19.85%
Product Systems and software products
1.69M
4.57%
Services: Capital equipment and other
1.41M
3.81%

Distribuição de ações

Atualizado em: qua, 13 de mai
Atualizado em: qua, 13 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.04%
MAK Capital One, LLC
5.77%
Bigger Capital Funds, LP
4.54%
Vanguard Capital Management, LLC
4.15%
PTC Therapeutics Inc
2.98%
Outro
76.52%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.04%
MAK Capital One, LLC
5.77%
Bigger Capital Funds, LP
4.54%
Vanguard Capital Management, LLC
4.15%
PTC Therapeutics Inc
2.98%
Outro
76.52%
Tipos de investidores
Investidores
Proporção
Investment Advisor
24.64%
Hedge Fund
15.56%
Investment Advisor/Hedge Fund
9.43%
Individual Investor
5.49%
Corporation
2.98%
Research Firm
2.62%
Bank and Trust
0.14%
Venture Capital
0.07%
Pension Fund
0.03%
Outro
39.04%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
266
15.83M
52.78%
+1.86M
2025Q4
238
11.91M
42.82%
-795.00
2025Q3
241
11.91M
44.93%
+805.07K
2025Q2
228
11.11M
37.29%
+1.29M
2025Q1
216
9.82M
36.04%
-268.85K
2024Q4
204
9.20M
33.04%
+1.04M
2024Q3
190
8.15M
32.05%
-235.56K
2024Q2
185
8.39M
33.08%
-454.38K
2024Q1
183
8.85M
30.95%
+359.48K
2023Q4
183
7.82M
35.41%
+717.11K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
1.81M
6.11%
+184.35K
+11.33%
Dec 31, 2025
MAK Capital One, LLC
1.73M
5.83%
+1.73M
--
Mar 10, 2026
Bigger Capital Funds, LP
1.33M
4.49%
+40.78K
+3.16%
Dec 31, 2025
PTC Therapeutics Inc
894.58K
3.02%
--
--
Aug 23, 2024
Geode Capital Management, L.L.C.
654.35K
2.21%
-2.05K
-0.31%
Dec 31, 2025
State Street Investment Management (US)
628.06K
2.12%
+145.41K
+30.13%
Dec 31, 2025
Millennium Management LLC
515.38K
1.74%
+327.57K
+174.43%
Dec 31, 2025
StemPoint Capital LP
481.86K
1.62%
+465.21K
+2793.87%
Dec 31, 2025
UBS Financial Services, Inc.
339.81K
1.15%
-20.89K
-5.79%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
1.19%
iShares Neuroscience and Healthcare ETF
0.94%
iShares Micro-Cap ETF
0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
Vanguard US Momentum Factor ETF
0.06%
Motley Fool Next Index ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção1.19%
iShares Neuroscience and Healthcare ETF
Proporção0.94%
iShares Micro-Cap ETF
Proporção0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.09%
Vanguard US Momentum Factor ETF
Proporção0.06%
Motley Fool Next Index ETF
Proporção0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0.03%
iShares Russell 2000 Growth ETF
Proporção0.03%
iShares Russell 2000 ETF
Proporção0.02%
Proshares Ultra Russell 2000
Proporção0.02%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI